Table 7 Significantly expressed oral metabolites with antifungal properties across study groups.

From: Metabolomic profiling reveals alterations in Candida pathophysiology and host interactions during primary oral candidiasis and following antifungal treatment

Metabolites

Antifungal properties

Fatty acids (FA)

Linoleamide

Inhibits Candida hyphal growth, serves as a signaling molecule to reduce inflammation in host88

Palmitic amide

Mimics farnesol and interferes quorum sensing, causes biofilm and hyphal inhibition89

Stearamide

Compromises cell membrane integrity, causes disintegration of fungal cells90

undecan-2-one

Disrupts cell wall and membrane structures, causes intracellular lysate leakage and induction of oxidative stress77

Glycerolipid (GL)

1-monopalmitin

Disrupts the function of Candida cell membrane91

Carboxylic acids (CA) and derivatives

Dichloroacetate

Inhibits glycolysis by affecting the regulation of pyruvate dehydrogenase92

Organonitrogen compounds

Cyclohexylammonium

Inhibits polyamine synthesis and Candida growth93

Furans

Isolimonic acid

Induces reactive oxygen species and apoptosis, reducing Candida virulence94